A Retrospective Breast Reconstruction Study

CompletedOBSERVATIONAL
Enrollment

223

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

March 14, 2022

Study Completion Date

June 1, 2022

Conditions
Breast Cancer
Interventions
OTHER

SimpliDerm HADM

Human acellular dermal matrices are used for the repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

OTHER

AlloDerm HADM

Human acellular dermal matrices are used for the repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

OTHER

AlloMax HADM

Human acellular dermal matrices are used for the repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

OTHER

FlexHD HADM

Human acellular dermal matrices are used for the repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

OTHER

DermACELL HADM

Human acellular dermal matrices are used for the repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.

Trial Locations (5)

35661

Shoals Plastic Surgery, Muscle Shoals

36116

Baptist Medical Center South, Montgomery

37203

Tierney Plastic Surgery, Nashville

78504

DHR Health, McAllen

78731

Ascension/Seton Institute of Reconstructive Plastic Surgery, Austin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Elutia Inc.

INDUSTRY

NCT04060134 - A Retrospective Breast Reconstruction Study | Biotech Hunter | Biotech Hunter